Medcity Pivot Podcast
-
MedCity Pivot Podcast: Tackling Rare Disease With Someone Who Was Touched By It
Rich Horgan believes that there’s an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases.
-
MedCity Pivot Podcast: A Conversation With Unlearn.AI CEO About Clinical Trials
The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Pivot Podcast: Season 3 Launches With A Conversation On the Potential Toxicity of Immunotherapy
Transformations in the Life Sciences is the focus of the second season of the MedCity Pivot Podcast. My personal journey as a caregiver of a cancer patient made me choose Dr. Sumanta Pal, co-director of the City of Hope’s Liver Cancer program as a guest after he co-authored an interesting study on immunotherapy that was published in the Lancet.
-
MedCity Pivot Podcast: 2 Perspectives on how AI Can Soothe Burnout, Burden of Prior Authorization
I interview Punit Singh Soni, CEO of Suki and Niall O’Connor, CTO, Cohere Health to evaluate two areas where AI can have an outsize impact: clinical documentation and prior authorization.
-
MedCity Pivot Podcast: It’s Time To Talk About Responsible AI
A conversation with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab about responsible AI.
-
Devices & Diagnostics, Artificial Intelligence
Season 2 of MedCity Pivot Podcast Launches with Conversation of Zephyr AI CTO
Season 2 of our MedCity Pivot Podcast launches today with a conversation about how AI can be leveraged to transform precision medicine.
-
MedCity Pivot: Blue Shield of California CEO Says Value of HealthTech Has Been Mixed So Far
Paul Markovich believes in the value of health tech in managing both chronic diseases and in general health and wellness. In this episode, he talks about the company’s Wellvolution platform and the digital tools that are offered there to members, now even to those on Medicaid.
-
Medcity Pivot Podcast: Chronic Disease Management With an Interventional Cardiologist
Steve Driver is an interventional cardiologist as well as medical director of digital therapeutics at Advocate Aurora Health, which last year merged with Atrium Health. In this episode, he talked about a pilot involving Omada Health targeting a prediabetes population, among other things.
-
MedCity Pivot Podcast Season 1 Launches With Focus on Chronic Disease Management
Season one focusing on chronic disease management kicks off with a conversation with Stephanie Tilenius, CEO of Vida Health that aims to treat both the mind and the body.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
MedCity Pivot Podcast: What does the CEO of Zocdoc believe the future of telehealth to be?
Kharraz made a bold declaration about telehealth back in December 2020. In the final episode of 2022, we ask him about that and more.
-
Medcity Pivot Podcast: A Conversation With COTA CEO Miruna Sasu About RWE
Miruna Sasu, CEO of RWE company COTA, explained that studies have shown meaningful improvements in efficiency if RWE is used in drug development and that translates into real savings. However, will such efforts continue amidst the ongoing belt-tightening in a tough economy?
-
MedCity Pivot podcast: A chat with executive search firm CEO Sonia Millsom
In this episode, we are conversing with Sonia Millsom, CEO of executive search firm Oxeon, to discuss trends shaping the marketplace following the Great Resignation as well as how Oxeon is spurring innovation through its venture studio.
-
MedCity Pivot Podcast: A conversation with Gilead Sciences VP Anu Osinusi
Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusi talked about the pharma company’s work in HIV and hepatitis and how her personal background informed her team’s work in developing a Covid-19 treatment.
-
Consumer / Employer, Health Tech
Pivot Podcast: Hinge Health CEO Dan Perez exhorts all healthtech firms to validate, publish results
Digital health technologies have received plenty of attention, cash and sky-high valuations but do they deserve it? In the latest episode of MedCity’s Pivot podcast, CEO of Hinge Health says companies need to validate their results in order to move the industry forward.
-
MedCity Pivot Podcast: A conversation with Renee Ryan, CEO of Cala Health
Renee Ryan hopes to see the vision of Cala Health’s founder – who believed that Cala Health’s wearable neurostimulation device can be one of the treatment modalities for chronic diseases like essential tremor – translated to reality.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
